Acylated and unacylated ghrelin dosages ( DrugBank: Ghrelin )

---

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
193	プラダー・ウィリ症候群	1
201	アンジェルマン症候群	1
202	スミス・マギニス症候群	1

193. プラダー・ウィリ症候群

---

臨床試験数 : 111 /  薬物数 : 120 - (DrugBank : 30) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 103

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04768803 (ClinicalTrials.gov)	March 15, 2021	16/2/2021	Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity	Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity	Angelman Syndrome;Smith-Magenis Syndrome;X Fragile Syndrome;Epilepsy;Prader-Willi Syndrome	Biological: acylated and unacylated ghrelin dosages	University Hospital, Toulouse	NULL	Not yet recruiting	3 Years	50 Years	All	300		NULL

201. アンジェルマン症候群

---

臨床試験数 : 24 /  薬物数 : 35 - (DrugBank : 9) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04768803 (ClinicalTrials.gov)	March 15, 2021	16/2/2021	Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity	Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity	Angelman Syndrome;Smith-Magenis Syndrome;X Fragile Syndrome;Epilepsy;Prader-Willi Syndrome	Biological: acylated and unacylated ghrelin dosages	University Hospital, Toulouse	NULL	Not yet recruiting	3 Years	50 Years	All	300		NULL

202. スミス・マギニス症候群

---

臨床試験数 : 10 /  薬物数 : 12 - (DrugBank : 5) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 7

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04768803 (ClinicalTrials.gov)	March 15, 2021	16/2/2021	Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity	Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity	Angelman Syndrome;Smith-Magenis Syndrome;X Fragile Syndrome;Epilepsy;Prader-Willi Syndrome	Biological: acylated and unacylated ghrelin dosages	University Hospital, Toulouse	NULL	Not yet recruiting	3 Years	50 Years	All	300		NULL